Clinical Trials Logo

Rhinitis, Allergic, Perennial clinical trials

View clinical trials related to Rhinitis, Allergic, Perennial.

Filter by:

NCT ID: NCT01135134 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)

Start date: June 2010
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, parallel design, double-blind study of mometasone furoate (MF) in pediatric subjects with perennial allergic rhinitis. The subjects 5 to 15 years of age with perennial allergic rhinitis will enter a no-treatment observation period of 7 days at minimum and eligibility for inclusion in this study will be assessed. Following the observation period, eligible subjects will be randomized to MF or MF placebo for a 2-week double-blind treatment. At each clinic visit (at the start of treatment and after 1 and 2 weeks of treatment or at discontinuation), nasal symptom scores, nasal findings, and adverse events (AEs), will be evaluated. A 30-day follow-up visit will take place after the completion (or discontinuation) of the 2-week treatment period, to confirm presence or absence of serious adverse events (SAEs) and trial procedure-related AEs.

NCT ID: NCT01134705 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of perennial allergic rhinitis.

NCT ID: NCT01133626 Completed - Clinical trials for Perennial Allergic Rhinitis

Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

Start date: June 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the effects of BDP HFA Nasal Aerosol on HPA-axis function.

NCT ID: NCT01127620 Completed - Clinical trials for Perennial Allergic Rhinitis

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Start date: May 2004
Phase: Phase 3
Study type: Interventional

Double-blind phase: The objective of the study was to evaluate the efficacy and safety of Bilastine 20 mg, compared to Cetirizine and placebo for the treatment of perennial allergic rhinitis. Open-label Phase: The objective of this extension was to evaluate the long-term safety of Bilastine 20 mg during one year in the symptomatic treatment of perennial allergic rhinitis

NCT ID: NCT01116778 Completed - Clinical trials for Perennial Allergic Rhinitis

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis

PAR
Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of probiotics eN-Lac® capsules (Lactobacillus paracasei GMNL-32) for the treatment of children with perennial allergic rhinitis(PAR).

NCT ID: NCT01115595 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by - symptoms score - medication score - quality of life - immunologic test from blood

NCT ID: NCT01077609 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Flixonase Safety in Patients With Allergic Rhinitis (AR)

Start date: January 2008
Phase: N/A
Study type: Observational

This is an inception cohort study that analyses data from an administrative medical records database. The two inception cohorts are: 1) patients initiated on intranasal FP and 2) patients initiated on another INS (not FP). The candidates for the inception cohorts did not use any intranasal steroid in the year prior to initiation.

NCT ID: NCT01067105 Completed - Clinical trials for Perennial Allergic Rhinitis

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Start date: February 2010
Phase: Phase 3
Study type: Interventional

6-month safety extension study in subjects who have completed Study 060-633 (NCT00953147). Evaluating the long-term safety of ciclesonide HFA nasal aerosol 160 μg administered once-daily in patients with Perennial Allergic Rhinitis.

NCT ID: NCT01062139 Enrolling by invitation - Clinical trials for Perennial Allergic Rhinitis

Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy

Start date: October 2009
Phase: Phase 4
Study type: Interventional

Title of Study: A randomized, parallel, double-blind, multi-center, comparative study to evaluate the efficacy and safety of Cosalin monotherapy versus Cosalin and Xarlin combination therapy in patients with allergic rhinitis Objective of study: To exploratively evaluate superiority of combination therapy - twice-daily Cosalin Tab (Petasites hybridus CO2 extract) with once-daily Xarlin Tab (Levocetirizine HCl) - compared to monotherapy of Cosalin with allergic rhinitis subjects.

NCT ID: NCT01033825 Completed - Clinical trials for Perennial Allergic Rhinitis

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Start date: January 2010
Phase: Phase 3
Study type: Interventional

To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.